Abstract
Histone lysine acetylation is central to epigenetic control of gene transcription. The bromodomain, found in chromatin-associated proteins and histone acetyltranferases, functions as the sole protein module known to bind acetyl-lysine motifs. Recent structural and functional analyses of bromodomains' recognition of lysine-acetylated peptides derived from major acetylation sites in histones and cellular proteins provide new insights into differences in ligand binding selectivity as well as unifying features of histone recognition by the bromodomains. These new findings highlight the functional importance of bromodomain/acetyl-lysine binding as a pivotal mechanism for regulating protein–protein interactions in histone-directed chromatin remodeling and gene transcription. These new studies also support the notion that functional diversity of a conserved bromodomain structural fold is achieved by evolutionary changes of structurally flexible amino-acid sequences in the ligand binding site such as the ZA and BC loops.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CBP:
-
CREB-binding protein
- PCAF:
-
p300/CBP-associated factor
References
Allfrey VG, Faulkner R, Mirsky AE . (1964). Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51: 786–794.
Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC et al. (2001). Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410: 120–124.
Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD et al. (2001). Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8: 1243–1254.
Berger J, Bird A . (2005). Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans 33: 1537–1540.
Berger SL . (2002). Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12: 142–148.
Cairns BR, Schlichter A, Erdjument-Bromage H, Tempst P, Kornberg RD, Winston F . (1999). Two functionally distinct forms of the RSC nucleosome-remodeling complex, containing essential AT hook, BAH, and bromodomains. Mol Cell 4: 715–723.
Carey M, Li B, Workman JL . (2006). RSC exploits histone acetylation to abrogate the nucleosomal block to RNA polymerase II elongation. Mol Cell 24: 481–487.
Chua P, Roeder GS . (1995). Bdf1, a yeast chromosomal protein required for sporulation. Mol Cell Biol 15: 3685–3696.
Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS et al. (2004). Regulation of p53 activity through lysine methylation. Nature 432: 353–360.
Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K . (2003). The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci USA 100: 8758–8763.
Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, Sciortino S et al. (2000). A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol Cell Biol 20: 6537–6549.
Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM . (1999). Structure and ligand of a histone acetyltransferase bromodomain. Nature 399: 491–496.
Dorr A, Kiermer V, Pedal A, Rackwitz HR, Henklein P, Schubert U et al. (2002). Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J 21: 2715–2723.
Du J, Nasir I, Benton BK, Kladde MP, Laurent BC . (1998). Sth1p, a Saccharomyces cerevisiae Snf2p/Swi2p homolog, is an essential ATPase in RSC and differs from Snf/Swi in its interactions with histones and chromatin-associated proteins. Genetics 150: 987–1005.
Fischle W, Wang Y, Allis CD . (2003). Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172–183.
Fujiki R, Kim MS, Sasaki Y, Yoshimura K, Kitagawa H, Kato S . (2005). Ligand-induced transrepression by VDR through association of WSTF with acetylated histones. EMBO J 24: 3881–3894.
Georgakopoulos T, Gounalaki N, Thireos G . (1995). Gentic evidence for the interaction of the yeast transcriptional co-activator proteins GCN5 and ADA2. Mol Gen Genet 246: 723–728.
Greenwald RJ, Tumang JR, Sinha A, Currier N, Cardiff RD, Rothstein TL et al. (2004). E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood 103: 1475–1484.
Hassan AH, Awad S, Prochasson P . (2006). The Swi2/Snf2 bromodomain is required for the displacement of SAGA and the octamer transfer of SAGA-acetylated nucleosomes. J Biol Chem 281: 18126–18134.
Hassan AH, Neely KE, Workman JL . (2001). Histone acetyltransferase complexes stabilize swi/snf binding to promoter nucleosomes. Cell 104: 817–827.
Hassan AH, Prochasson P, Neely KE, Galasinski SC, Chandy M, Carrozza MJ et al. (2002). Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111: 369–379.
Haupt Y, Maya R, Kazaz A, Oren M . (1997). Mdm2 promotes the rapid degradation of p53. Nature 387: 296–299.
Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, Dorsey JA et al. (2006). Repression of p53 activity by Smyd2-mediated methylation. Nature 444: 629–632.
Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE . (2000). Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. J Mol Biol 304: 355–370.
Jacobs SA, Khorasanizadeh S . (2002). Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science 295: 2080–2083.
Jacobson RH, Ladurner AG, King DS, Tjian R . (2000). Structure and function of a human TAFII250 double bromodomain module. Science 288: 1422–1425.
Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K . (2005). The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19: 523–534.
Jeanmougin F, Wurtz JM, Le Douarin B, Chambon P, Losson R . (1997). The bromodomain revisited. Trends Biochem Sci 22: 151–153.
Jenuwein T, Allis CD . (2001). Translating the histone code. Science 293: 1074–1080.
Kasten M, Szerlong H, Erdjument-Bromage H, Tempst P, Werner M, Cairns BR . (2004). Tandem bromodomains in the chromatin remodeler RSC recognize acetylated histone H3 Lys14. EMBO J 23: 1348–1359.
Kouzarides T . (2007). Chromatin modifications and their function. Cell 128: 693–705.
Kubbutat MH, Jones SN, Vousden KH . (1997). Regulation of p53 stability by Mdm2. Nature 387: 299–303.
Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T . (2001). Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116–120.
Ladurner AG, Inouye C, Jain R, Tjian R . (2003). Bromodomains mediate an acetyl-histone encoded antisilencing function at heterochromatin boundaries. Mol Cell 11: 365–376.
Lemon B, Inouye C, King DS, Tjian R . (2001). Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. Nature 414: 924–928.
Li B, Carey M, Workman JL . (2007). The role of chromatin during transcription. Cell 128: 707–719.
Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD et al. (2006). Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442: 91–95.
Martinez-Campa C, Politis P, Moreau JL, Kent N, Goodall J, Mellor J et al. (2004). Precise nucleosome positioning and the TATA box dictate requirements for the histone H4 tail and the bromodomain factor Bdf1. Mol Cell 15: 69–81.
Muchardt C, Bourachot B, Reyes JC, Yaniv M . (1998). Ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J 17: 223–231.
Muchardt C, Yaniv M . (1999). The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol 10: 189–195.
Mujtaba S, He Y, Zeng L, Farooq A, Carlson JE, Ott M et al. (2002). Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell 9: 575–586.
Mujtaba S, He Y, Zeng L, Yan S, Plotnikova O, Sachchidanand et al. (2004). Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell 13: 251–263.
Nakamura Y, Umehara T, Nakano K, Jang MK, Shirouzu M, Morita S et al. (2007). Crystal structure of the human BRD2 bromodomain: Insights into dimerization and recognition of acetylated histone h4. J Biol Chem 282: 4193–4201.
Neely KE, Workman JL . (2002). Histone acetylation and chromatin remodeling: which comes first? Mol Genet Metab 76: 1–5.
Nielsen PR, Nietlispach D, Mott HR, Callaghan J, Bannister A, Kouzarides T et al. (2002). Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature 416: 103–107.
Owen DJ, Ornaghi P, Yang JC, Lowe N, Evans PR, Ballario P et al. (2000). The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J 19: 6141–6149.
Pena PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O et al. (2006). Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442: 100–103.
Qiu J . (2006). Epigenetics: unfinished symphony. Nature 441: 143–145.
Ruthenburg AJ, Allis CD, Wysocka J . (2007). Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25: 15–30.
Sachchidanand, Resnick-Silverman L, Yan S, Mutjaba S, Liu WJ, Zeng L et al. (2006). Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol 13: 81–90.
Schweiger MR, You J, Howley PM . (2006). Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol 80: 4276–4285.
Shen W, Xu C, Huang W, Zhang J, Carlson JE, Tu X et al. (2007). Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry 46: 2100–2110.
Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T et al. (2006). ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442: 96–99.
Strahl BD, Allis CD . (2000). The language of covalent histone modifications. Nature 403: 41–45.
Syntichaki P, Topalidou I, Thireos G . (2000). The Gcn5 bromodomain co-ordinates nucleosome remodelling. Nature 404: 414–417.
Turner BM . (1998). Histone acetylation as an epigenetic determinant of long-term transcriptional competence. Cell Mol Life Sci 54: 21–31.
Turner BM . (2002). Cellular memory and the histone code. Cell 111: 285–291.
Workman JL . (2006). Nucleosome displacement in transcription. Genes Dev 20: 2009–2017.
Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J et al. (2006). A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442: 86–90.
Zeng L, Li J, Muller M, Yan S, Mujtaba S, Pan C et al. (2005). Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J Am Chem Soc 127: 2376–2377.
Zeng L, Zhou MM . (2002). Bromodomain: an acetyl-lysine binding domain. FEBS Lett 513: 124–128.
Zhou Y, Grummt I . (2005). The PHD finger/bromodomain of NoRC interacts with acetylated histone H4K16 and is sufficient for rDNA silencing. Curr Biol 15: 1434–1438.
Acknowledgements
This work was supported by grants from the National Institutes of Health (M-MZ and SM) and by the funding from the National Science Foundation and the Dr Harold and Golden Lamport Chair (M-MZ).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mujtaba, S., Zeng, L. & Zhou, MM. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26, 5521–5527 (2007). https://doi.org/10.1038/sj.onc.1210618
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210618
Keywords
This article is cited by
-
Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy
Signal Transduction and Targeted Therapy (2023)
-
Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors
Oncogene (2020)
-
Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells
Oncogene (2020)
-
BRD7 deficiency leads to the development of obesity and hyperglycemia
Scientific Reports (2019)
-
BET Inhibition Improves NASH and Liver Fibrosis
Scientific Reports (2018)